New Disulfiram Derivatives as MAGL-Selective Inhibitors
Monoacylglycerol lipase (MAGL) is a key enzyme in the human endocannabinoid system. It is also the main enzyme responsible for the conversion of 2-arachidonoyl glycerol (2-AG) to arachidonic acid (AA), a precursor of prostaglandin synthesis. The inhibition of MAGL activity would be beneficial for th...
Main Author: | Ziad Omran |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/11/3296 |
Similar Items
-
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
by: Alessandro Papa, et al.
Published: (2022-01-01) -
Levels of endocannabinoid metabolizing enzymes are not related with BDNF levels in patients with schizophrenia: a case-controlled study
by: Mehmet Cemal Kaya, et al.
Published: (2019-10-01) -
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
by: Robert Ramer, et al.
Published: (2019-05-01) -
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
by: Carlotta Granchi, et al.
Published: (2017-01-01) -
Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors
by: Ziad Omran
Published: (2022-01-01)